Taxiclot 500 mg (Capsule)

Unit Price: ৳ 15.00 (2 x 10: ৳ 300.00)
Strip Price: ৳ 150.00

Medicine Details

Category Details
Generic Tranexamic acid
Company One pharma ltd

Product Title

  • Taxiclot - Tranexamic Acid Hemostatic Medication

Categories

  • Medicine
  • Hemostatic Drugs
  • Anti-fibrinolytic Drugs

Description

  • Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
  • Pharmacology description of Tranexamic Acid and its antifibrinolytic action
  • Dosage and administration information for adults, children, and elderly patients
  • Details about potential drug interactions with penicillins, thrombolytic drugs, and estrogen-containing drugs
  • Contraindications for individuals with known hypersensitivity, thromboembolic disease, serious kidney failure
  • Potential side effects including fatigue, conjunctival irritation, nausea, and postural hypotension
  • Guidelines for use during pregnancy and lactation, and precautions and warnings for specific conditions

Dimensions

  • N/A

Weight

  • N/A

Color Options

  • N/A

Materials

  • Tranexamic Acid (trans-4 aminomethyl-cyclohexanecarboxylic acid)

Technical Specifications

  • Low acute toxicity and almost non-existent chronic toxicity
  • Well absorbed by oral route with effect seen 15-30 minutes after administration
  • Mainly excreted by renal route

Design Elements

  • Ampoule (500 mg)
  • Capsules
  • Sweetened Water for oral administration

Usability Features

  • Long-lasting effect due to slow excretion by renal route
  • Easy oral and parenteral (intravenous or intramuscular) administration

Functions

  • Prophylaxis and therapy for various medical indications including surgery, urology, obstetrics, otorhinolaryngology, stomatology, and oncology

Safety Features

  • Should not be used in cases of serious renal insufficiency or anuric syndromes
  • Careful administration in cardiopathic and hepatopathic subjects

Age Demographic

  • Adults, Children, Elderly patients

Special Features

  • Inhibits plasminogen activation and possesses antifibrinolytic mechanism
  • Therapeutic doses do not interfere with clotting processes
  • Considerably lower single doses can be administered at greater intervals

Unique Selling Propositions

  • 10 times more active than conventional hemostatics
  • Antihemorrhagic action in a variety of conditions

Brand

  • Taxiclot

Manufacturer

  • N/A

Power Source

  • N/A

Additional Accessories

  • N/A

Maintenance

  • N/A

Warranty

  • N/A

Certifications

  • N/A

Compliance

  • N/A

Included in the Box

  • N/A

Assembly Required

  • N/A

Mobility

  • N/A

Country of Origin

  • N/A

Sustainability Features

  • N/A

Environmental Impact

  • N/A

Sustainability Certification

  • N/A

Recyclable

  • N/A

Biodegradable

  • N/A

Disposal

  • N/A

Eco-friendly

  • N/A

Packaging Materials

  • N/A

Packaging Dimensions

  • N/A

Packaging Weight

  • N/A

Regulatory Compliance

  • N/A

Legal Disclaimer

  • N/A

Customer Support

  • N/A

Product Information Updates

  • N/A

Storage Conditions

  • Store in a dry place at 15-30°C, away from light and keep out of children's reach

Related Brands